Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Senanayake Chris
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Vander Hoek Michael
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Milton
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jacobs Bette
Shuttle Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AFH Holding & Advisory, LLC (EIN – – Amir F. Heshmatpour(3.80%)
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dritschilo Anatoly
Shuttle Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-AFH Holding & Advisory, LLC (EIN – – Amir F. Heshmatpour(9.14%)
Shuttle Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-AFH Holding & Advisory, LLC(11.5%)
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Milton
Shuttle Pharmaceuticals | D: Filing D
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Richards Steven M
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Former Director Adkins William
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Milton
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dritschilo Anatoly
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rich Tyvin
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jung Mira
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jacobs Bette
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dritschilo Peter
Shuttle Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Vander Hoek Michael
Shuttle Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Jacobs Bette
No Data